CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Potential applications of macrophages in cancer immunotherapy.
Potential applications of macrophages in cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫治疗基于对肿瘤免疫逃逸的研究改善了癌症治疗。操纵免疫系统可刺激抗肿瘤免疫反应并阻断肿瘤免疫逃逸途径。基因改造的过继性细胞疗法,如 T 细胞,已在血液系统恶性肿瘤中取得了有希望的结果,但其在实体瘤中的应用一直具有挑战性。巨噬细胞在调节免疫反应、稳态和组织发育方面具有广泛的能力,以及具有吞噬、呈递抗原和浸润肿瘤微环境(TME)的能力。鉴于巨噬细胞在癌症发展中的重要性,它们可以作为肿瘤治疗的新工具。因此,巨噬细胞以不同形式用于直接和间接靶向肿瘤细胞。本综述总结了巨噬细胞在癌症免疫治疗中各种应用的现有数据。
Immunotherapy has improved cancer treatment based on investigations of tumor immune escape. Manipulation of the immune system stimulates antitumor immune responses and blocks tumor immune escape routes. Genetically adoptive cell therapy, such as T cells, has yielded promising results for hematologic malignancies, but their application to solid tumors has been challenging.
Macrophages have a wide broad of capabilities in regulating immune responses, homeostasis, and tissue development, as well as the ability to phagocyte, present antigens, and infiltrate the tumor microenvironment (TME). Given the importance of macrophages in cancer development, they could serve as novel tool for tumor treatment.
Therefore, macrophages are used in different formats for direct and indirect targeting of tumor cells. This review summarized the available data on the various applications of macrophages in cancer immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。